Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Total Liabilities (2020 - 2025)

Stemtech (STEK) has disclosed Total Liabilities for 6 consecutive years, with $10.3 million as the latest value for Q3 2025.

  • Quarterly Total Liabilities changed N/A to $10.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Sep 2025, changed N/A year-over-year, with the annual reading at $9.0 million for FY2024, 39.42% up from the prior year.
  • Total Liabilities hit $10.3 million in Q3 2025 for Stemtech, roughly flat from $10.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $33.5 million in Q2 2022 to a low of -$896097.0 in Q1 2021.
  • Historically, Total Liabilities has averaged $9.0 million across 5 years, with a median of $9.0 million in 2022.
  • Biggest five-year swings in Total Liabilities: surged 13408.51% in 2022 and later tumbled 82.94% in 2023.
  • Year by year, Total Liabilities stood at $9.7 million in 2021, then dropped by 23.51% to $7.4 million in 2022, then fell by 13.13% to $6.5 million in 2023, then surged by 39.42% to $9.0 million in 2024, then increased by 14.35% to $10.3 million in 2025.
  • Business Quant data shows Total Liabilities for STEK at $10.3 million in Q3 2025, $10.3 million in Q2 2025, and $9.4 million in Q1 2025.